{
    "2020-07-30": [
        [
            {
                "time": "2020-11-01",
                "original_text": "U.S. government to launch 'overwhelming' COVID-19 vaccine campaign by November",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "vaccine",
                        "campaign"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-15",
                "original_text": "Johnson & Johnson stock outperforms market on strong trading day",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "stock",
                        "outperforms",
                        "market",
                        "strong trading day"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-03",
                "original_text": "Pfizer Covid-19 Vaccine Sales Could Hit $15 Billion",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Covid-19",
                        "Vaccine",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-20",
                "original_text": "Cross-Sector: Market Data Highlights",
                "features": {
                    "keywords": [
                        "Market",
                        "Data",
                        "Highlights"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cross-sector"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-25",
                "original_text": "What Kind Of Shareholders Hold The Majority In Pfizer Inc.'s (NYSE:PFE) Shares?",
                "features": {
                    "keywords": [
                        "Shareholders",
                        "Pfizer",
                        "Inc."
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-23",
                "original_text": "Johnson & Johnson Begins Trial of Covid-19 Vaccine in One-Dose Regimen",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Trial",
                        "Covid-19",
                        "Vaccine",
                        "One-Dose Regimen"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-10",
                "original_text": "Influencers with Andy Serwer: Bill Gates",
                "features": {
                    "keywords": [
                        "Influencers",
                        "Andy Serwer",
                        "Bill Gates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "Bill Gates: We should be able 'to manufacture a lot of vaccines in 2021'",
                "features": {
                    "keywords": [
                        "Bill Gates",
                        "manufacture",
                        "vaccines",
                        "2021"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-18",
                "original_text": "China to add 56 drugs to price-slashing bulk-buy programme",
                "features": {
                    "keywords": [
                        "China",
                        "drugs",
                        "price-slashing",
                        "bulk-buy",
                        "programme"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}